nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadodiamide—Chills—Paclitaxel—ovarian cancer	0.00149	0.00149	CcSEcCtD
Gadodiamide—Renal failure acute—Epirubicin—ovarian cancer	0.00149	0.00149	CcSEcCtD
Gadodiamide—Arrhythmia—Paclitaxel—ovarian cancer	0.00148	0.00148	CcSEcCtD
Gadodiamide—Hypersensitivity—Melphalan—ovarian cancer	0.00148	0.00148	CcSEcCtD
Gadodiamide—Phlebitis—Doxorubicin—ovarian cancer	0.00148	0.00148	CcSEcCtD
Gadodiamide—Asthenia—Topotecan—ovarian cancer	0.00147	0.00147	CcSEcCtD
Gadodiamide—Hot flush—Epirubicin—ovarian cancer	0.00147	0.00147	CcSEcCtD
Gadodiamide—Vomiting—Chlorambucil—ovarian cancer	0.00147	0.00147	CcSEcCtD
Gadodiamide—Menopausal symptoms—Epirubicin—ovarian cancer	0.00146	0.00146	CcSEcCtD
Gadodiamide—Pruritus—Topotecan—ovarian cancer	0.00145	0.00145	CcSEcCtD
Gadodiamide—Feeling abnormal—Vinorelbine—ovarian cancer	0.00145	0.00145	CcSEcCtD
Gadodiamide—Renal impairment—Epirubicin—ovarian cancer	0.00144	0.00144	CcSEcCtD
Gadodiamide—Asthenia—Melphalan—ovarian cancer	0.00144	0.00144	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00144	0.00144	CcSEcCtD
Gadodiamide—Pruritus—Melphalan—ovarian cancer	0.00142	0.00142	CcSEcCtD
Gadodiamide—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.00142	0.00142	CcSEcCtD
Gadodiamide—Dysgeusia—Paclitaxel—ovarian cancer	0.00142	0.00142	CcSEcCtD
Gadodiamide—Rhinitis—Docetaxel—ovarian cancer	0.00141	0.00141	CcSEcCtD
Gadodiamide—Cardiac failure—Epirubicin—ovarian cancer	0.00141	0.00141	CcSEcCtD
Gadodiamide—Diarrhoea—Topotecan—ovarian cancer	0.0014	0.0014	CcSEcCtD
Gadodiamide—Pharyngitis—Docetaxel—ovarian cancer	0.0014	0.0014	CcSEcCtD
Gadodiamide—Urticaria—Vinorelbine—ovarian cancer	0.00139	0.00139	CcSEcCtD
Gadodiamide—Urinary tract disorder—Docetaxel—ovarian cancer	0.00139	0.00139	CcSEcCtD
Gadodiamide—Abdominal pain—Vinorelbine—ovarian cancer	0.00139	0.00139	CcSEcCtD
Gadodiamide—Body temperature increased—Vinorelbine—ovarian cancer	0.00139	0.00139	CcSEcCtD
Gadodiamide—Urethral disorder—Docetaxel—ovarian cancer	0.00138	0.00138	CcSEcCtD
Gadodiamide—Hyponatraemia—Epirubicin—ovarian cancer	0.00138	0.00138	CcSEcCtD
Gadodiamide—Renal failure acute—Doxorubicin—ovarian cancer	0.00138	0.00138	CcSEcCtD
Gadodiamide—Diarrhoea—Melphalan—ovarian cancer	0.00137	0.00137	CcSEcCtD
Gadodiamide—Nausea—Chlorambucil—ovarian cancer	0.00137	0.00137	CcSEcCtD
Gadodiamide—Hot flush—Doxorubicin—ovarian cancer	0.00136	0.00136	CcSEcCtD
Gadodiamide—Visual impairment—Docetaxel—ovarian cancer	0.00136	0.00136	CcSEcCtD
Gadodiamide—Dizziness—Topotecan—ovarian cancer	0.00136	0.00136	CcSEcCtD
Gadodiamide—Tremor—Paclitaxel—ovarian cancer	0.00136	0.00136	CcSEcCtD
Gadodiamide—Migraine—Epirubicin—ovarian cancer	0.00135	0.00135	CcSEcCtD
Gadodiamide—Menopausal symptoms—Doxorubicin—ovarian cancer	0.00135	0.00135	CcSEcCtD
Gadodiamide—Ill-defined disorder—Paclitaxel—ovarian cancer	0.00134	0.00134	CcSEcCtD
Gadodiamide—Renal impairment—Doxorubicin—ovarian cancer	0.00134	0.00134	CcSEcCtD
Gadodiamide—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.00131	0.00131	CcSEcCtD
Gadodiamide—Flushing—Docetaxel—ovarian cancer	0.00131	0.00131	CcSEcCtD
Gadodiamide—Vomiting—Topotecan—ovarian cancer	0.0013	0.0013	CcSEcCtD
Gadodiamide—Malaise—Paclitaxel—ovarian cancer	0.0013	0.0013	CcSEcCtD
Gadodiamide—Cardiac failure—Doxorubicin—ovarian cancer	0.0013	0.0013	CcSEcCtD
Gadodiamide—Syncope—Paclitaxel—ovarian cancer	0.0013	0.0013	CcSEcCtD
Gadodiamide—Rash—Topotecan—ovarian cancer	0.00129	0.00129	CcSEcCtD
Gadodiamide—Hypersensitivity—Vinorelbine—ovarian cancer	0.00129	0.00129	CcSEcCtD
Gadodiamide—Dermatitis—Topotecan—ovarian cancer	0.00129	0.00129	CcSEcCtD
Gadodiamide—Ataxia—Epirubicin—ovarian cancer	0.00129	0.00129	CcSEcCtD
Gadodiamide—Blood creatinine increased—Epirubicin—ovarian cancer	0.00129	0.00129	CcSEcCtD
Gadodiamide—Headache—Topotecan—ovarian cancer	0.00129	0.00129	CcSEcCtD
Gadodiamide—Vomiting—Melphalan—ovarian cancer	0.00128	0.00128	CcSEcCtD
Gadodiamide—Hyponatraemia—Doxorubicin—ovarian cancer	0.00128	0.00128	CcSEcCtD
Gadodiamide—Loss of consciousness—Paclitaxel—ovarian cancer	0.00127	0.00127	CcSEcCtD
Gadodiamide—Rash—Melphalan—ovarian cancer	0.00127	0.00127	CcSEcCtD
Gadodiamide—Dermatitis—Melphalan—ovarian cancer	0.00127	0.00127	CcSEcCtD
Gadodiamide—Chills—Docetaxel—ovarian cancer	0.00126	0.00126	CcSEcCtD
Gadodiamide—Asthenia—Vinorelbine—ovarian cancer	0.00126	0.00126	CcSEcCtD
Gadodiamide—Arrhythmia—Docetaxel—ovarian cancer	0.00126	0.00126	CcSEcCtD
Gadodiamide—Convulsion—Paclitaxel—ovarian cancer	0.00125	0.00125	CcSEcCtD
Gadodiamide—Migraine—Doxorubicin—ovarian cancer	0.00125	0.00125	CcSEcCtD
Gadodiamide—Pruritus—Vinorelbine—ovarian cancer	0.00124	0.00124	CcSEcCtD
Gadodiamide—Chest pain—Paclitaxel—ovarian cancer	0.00123	0.00123	CcSEcCtD
Gadodiamide—Myalgia—Paclitaxel—ovarian cancer	0.00123	0.00123	CcSEcCtD
Gadodiamide—Arthralgia—Paclitaxel—ovarian cancer	0.00123	0.00123	CcSEcCtD
Gadodiamide—Anxiety—Paclitaxel—ovarian cancer	0.00123	0.00123	CcSEcCtD
Gadodiamide—Nausea—Topotecan—ovarian cancer	0.00122	0.00122	CcSEcCtD
Gadodiamide—Discomfort—Paclitaxel—ovarian cancer	0.00122	0.00122	CcSEcCtD
Gadodiamide—Dry mouth—Paclitaxel—ovarian cancer	0.0012	0.0012	CcSEcCtD
Gadodiamide—Diarrhoea—Vinorelbine—ovarian cancer	0.0012	0.0012	CcSEcCtD
Gadodiamide—Dysgeusia—Docetaxel—ovarian cancer	0.0012	0.0012	CcSEcCtD
Gadodiamide—Ataxia—Doxorubicin—ovarian cancer	0.00119	0.00119	CcSEcCtD
Gadodiamide—Nausea—Melphalan—ovarian cancer	0.00119	0.00119	CcSEcCtD
Gadodiamide—Blood creatinine increased—Doxorubicin—ovarian cancer	0.00119	0.00119	CcSEcCtD
Gadodiamide—Oedema—Paclitaxel—ovarian cancer	0.00118	0.00118	CcSEcCtD
Gadodiamide—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00118	0.00118	CcSEcCtD
Gadodiamide—Infection—Paclitaxel—ovarian cancer	0.00117	0.00117	CcSEcCtD
Gadodiamide—Shock—Paclitaxel—ovarian cancer	0.00116	0.00116	CcSEcCtD
Gadodiamide—Dizziness—Vinorelbine—ovarian cancer	0.00116	0.00116	CcSEcCtD
Gadodiamide—Nervous system disorder—Paclitaxel—ovarian cancer	0.00116	0.00116	CcSEcCtD
Gadodiamide—Tachycardia—Paclitaxel—ovarian cancer	0.00115	0.00115	CcSEcCtD
Gadodiamide—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00114	0.00114	CcSEcCtD
Gadodiamide—Vomiting—Vinorelbine—ovarian cancer	0.00112	0.00112	CcSEcCtD
Gadodiamide—Rash—Vinorelbine—ovarian cancer	0.00111	0.00111	CcSEcCtD
Gadodiamide—Dermatitis—Vinorelbine—ovarian cancer	0.00111	0.00111	CcSEcCtD
Gadodiamide—Hypotension—Paclitaxel—ovarian cancer	0.0011	0.0011	CcSEcCtD
Gadodiamide—Headache—Vinorelbine—ovarian cancer	0.0011	0.0011	CcSEcCtD
Gadodiamide—Syncope—Docetaxel—ovarian cancer	0.0011	0.0011	CcSEcCtD
Gadodiamide—Loss of consciousness—Docetaxel—ovarian cancer	0.00108	0.00108	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00108	0.00108	CcSEcCtD
Gadodiamide—Convulsion—Docetaxel—ovarian cancer	0.00106	0.00106	CcSEcCtD
Gadodiamide—Paraesthesia—Paclitaxel—ovarian cancer	0.00106	0.00106	CcSEcCtD
Gadodiamide—Dyspnoea—Paclitaxel—ovarian cancer	0.00105	0.00105	CcSEcCtD
Gadodiamide—Somnolence—Paclitaxel—ovarian cancer	0.00105	0.00105	CcSEcCtD
Gadodiamide—Chest pain—Docetaxel—ovarian cancer	0.00104	0.00104	CcSEcCtD
Gadodiamide—Myalgia—Docetaxel—ovarian cancer	0.00104	0.00104	CcSEcCtD
Gadodiamide—Arthralgia—Docetaxel—ovarian cancer	0.00104	0.00104	CcSEcCtD
Gadodiamide—Nausea—Vinorelbine—ovarian cancer	0.00104	0.00104	CcSEcCtD
Gadodiamide—Renal failure—Epirubicin—ovarian cancer	0.00104	0.00104	CcSEcCtD
Gadodiamide—Dyspepsia—Paclitaxel—ovarian cancer	0.00104	0.00104	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Epirubicin—ovarian cancer	0.00104	0.00104	CcSEcCtD
Gadodiamide—Dry mouth—Docetaxel—ovarian cancer	0.00102	0.00102	CcSEcCtD
Gadodiamide—Fatigue—Paclitaxel—ovarian cancer	0.00102	0.00102	CcSEcCtD
Gadodiamide—Pain—Paclitaxel—ovarian cancer	0.00101	0.00101	CcSEcCtD
Gadodiamide—Anaphylactic shock—Docetaxel—ovarian cancer	0.001	0.001	CcSEcCtD
Gadodiamide—Oedema—Docetaxel—ovarian cancer	0.001	0.001	CcSEcCtD
Gadodiamide—Infection—Docetaxel—ovarian cancer	0.000994	0.000994	CcSEcCtD
Gadodiamide—Shock—Docetaxel—ovarian cancer	0.000985	0.000985	CcSEcCtD
Gadodiamide—Nervous system disorder—Docetaxel—ovarian cancer	0.000981	0.000981	CcSEcCtD
Gadodiamide—Tachycardia—Docetaxel—ovarian cancer	0.000977	0.000977	CcSEcCtD
Gadodiamide—Feeling abnormal—Paclitaxel—ovarian cancer	0.000973	0.000973	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000965	0.000965	CcSEcCtD
Gadodiamide—Renal failure—Doxorubicin—ovarian cancer	0.000963	0.000963	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.00096	0.00096	CcSEcCtD
Gadodiamide—Rhinitis—Epirubicin—ovarian cancer	0.000953	0.000953	CcSEcCtD
Gadodiamide—Pharyngitis—Epirubicin—ovarian cancer	0.000943	0.000943	CcSEcCtD
Gadodiamide—Urinary tract disorder—Epirubicin—ovarian cancer	0.000938	0.000938	CcSEcCtD
Gadodiamide—Urticaria—Paclitaxel—ovarian cancer	0.000938	0.000938	CcSEcCtD
Gadodiamide—Hypotension—Docetaxel—ovarian cancer	0.000935	0.000935	CcSEcCtD
Gadodiamide—Body temperature increased—Paclitaxel—ovarian cancer	0.000933	0.000933	CcSEcCtD
Gadodiamide—Abdominal pain—Paclitaxel—ovarian cancer	0.000933	0.000933	CcSEcCtD
Gadodiamide—Urethral disorder—Epirubicin—ovarian cancer	0.000931	0.000931	CcSEcCtD
Gadodiamide—Visual impairment—Epirubicin—ovarian cancer	0.000916	0.000916	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000912	0.000912	CcSEcCtD
Gadodiamide—Paraesthesia—Docetaxel—ovarian cancer	0.000899	0.000899	CcSEcCtD
Gadodiamide—Dyspnoea—Docetaxel—ovarian cancer	0.000892	0.000892	CcSEcCtD
Gadodiamide—Somnolence—Docetaxel—ovarian cancer	0.00089	0.00089	CcSEcCtD
Gadodiamide—Tinnitus—Epirubicin—ovarian cancer	0.000886	0.000886	CcSEcCtD
Gadodiamide—Flushing—Epirubicin—ovarian cancer	0.000882	0.000882	CcSEcCtD
Gadodiamide—Rhinitis—Doxorubicin—ovarian cancer	0.000881	0.000881	CcSEcCtD
Gadodiamide—Dyspepsia—Docetaxel—ovarian cancer	0.000881	0.000881	CcSEcCtD
Gadodiamide—Pharyngitis—Doxorubicin—ovarian cancer	0.000873	0.000873	CcSEcCtD
Gadodiamide—Hypersensitivity—Paclitaxel—ovarian cancer	0.00087	0.00087	CcSEcCtD
Gadodiamide—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000868	0.000868	CcSEcCtD
Gadodiamide—Fatigue—Docetaxel—ovarian cancer	0.000863	0.000863	CcSEcCtD
Gadodiamide—Urethral disorder—Doxorubicin—ovarian cancer	0.000862	0.000862	CcSEcCtD
Gadodiamide—Pain—Docetaxel—ovarian cancer	0.000856	0.000856	CcSEcCtD
Gadodiamide—Chills—Epirubicin—ovarian cancer	0.000853	0.000853	CcSEcCtD
Gadodiamide—Arrhythmia—Epirubicin—ovarian cancer	0.000849	0.000849	CcSEcCtD
Gadodiamide—Visual impairment—Doxorubicin—ovarian cancer	0.000847	0.000847	CcSEcCtD
Gadodiamide—Asthenia—Paclitaxel—ovarian cancer	0.000847	0.000847	CcSEcCtD
Gadodiamide—Pruritus—Paclitaxel—ovarian cancer	0.000835	0.000835	CcSEcCtD
Gadodiamide—Feeling abnormal—Docetaxel—ovarian cancer	0.000825	0.000825	CcSEcCtD
Gadodiamide—Tinnitus—Doxorubicin—ovarian cancer	0.00082	0.00082	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000818	0.000818	CcSEcCtD
Gadodiamide—Flushing—Doxorubicin—ovarian cancer	0.000816	0.000816	CcSEcCtD
Gadodiamide—Dysgeusia—Epirubicin—ovarian cancer	0.00081	0.00081	CcSEcCtD
Gadodiamide—Diarrhoea—Paclitaxel—ovarian cancer	0.000808	0.000808	CcSEcCtD
Gadodiamide—Abdominal pain—Docetaxel—ovarian cancer	0.000791	0.000791	CcSEcCtD
Gadodiamide—Body temperature increased—Docetaxel—ovarian cancer	0.000791	0.000791	CcSEcCtD
Gadodiamide—Chills—Doxorubicin—ovarian cancer	0.000789	0.000789	CcSEcCtD
Gadodiamide—Arrhythmia—Doxorubicin—ovarian cancer	0.000785	0.000785	CcSEcCtD
Gadodiamide—Dizziness—Paclitaxel—ovarian cancer	0.000781	0.000781	CcSEcCtD
Gadodiamide—Ill-defined disorder—Epirubicin—ovarian cancer	0.000767	0.000767	CcSEcCtD
Gadodiamide—Vomiting—Paclitaxel—ovarian cancer	0.000751	0.000751	CcSEcCtD
Gadodiamide—Dysgeusia—Doxorubicin—ovarian cancer	0.000749	0.000749	CcSEcCtD
Gadodiamide—Malaise—Epirubicin—ovarian cancer	0.000746	0.000746	CcSEcCtD
Gadodiamide—Rash—Paclitaxel—ovarian cancer	0.000744	0.000744	CcSEcCtD
Gadodiamide—Dermatitis—Paclitaxel—ovarian cancer	0.000744	0.000744	CcSEcCtD
Gadodiamide—Syncope—Epirubicin—ovarian cancer	0.000742	0.000742	CcSEcCtD
Gadodiamide—Headache—Paclitaxel—ovarian cancer	0.00074	0.00074	CcSEcCtD
Gadodiamide—Hypersensitivity—Docetaxel—ovarian cancer	0.000737	0.000737	CcSEcCtD
Gadodiamide—Loss of consciousness—Epirubicin—ovarian cancer	0.000727	0.000727	CcSEcCtD
Gadodiamide—Asthenia—Docetaxel—ovarian cancer	0.000718	0.000718	CcSEcCtD
Gadodiamide—Convulsion—Epirubicin—ovarian cancer	0.000717	0.000717	CcSEcCtD
Gadodiamide—Ill-defined disorder—Doxorubicin—ovarian cancer	0.00071	0.00071	CcSEcCtD
Gadodiamide—Pruritus—Docetaxel—ovarian cancer	0.000708	0.000708	CcSEcCtD
Gadodiamide—Myalgia—Epirubicin—ovarian cancer	0.000704	0.000704	CcSEcCtD
Gadodiamide—Arthralgia—Epirubicin—ovarian cancer	0.000704	0.000704	CcSEcCtD
Gadodiamide—Chest pain—Epirubicin—ovarian cancer	0.000704	0.000704	CcSEcCtD
Gadodiamide—Anxiety—Epirubicin—ovarian cancer	0.000702	0.000702	CcSEcCtD
Gadodiamide—Nausea—Paclitaxel—ovarian cancer	0.000701	0.000701	CcSEcCtD
Gadodiamide—Discomfort—Epirubicin—ovarian cancer	0.000696	0.000696	CcSEcCtD
Gadodiamide—Malaise—Doxorubicin—ovarian cancer	0.00069	0.00069	CcSEcCtD
Gadodiamide—Dry mouth—Epirubicin—ovarian cancer	0.000689	0.000689	CcSEcCtD
Gadodiamide—Syncope—Doxorubicin—ovarian cancer	0.000686	0.000686	CcSEcCtD
Gadodiamide—Diarrhoea—Docetaxel—ovarian cancer	0.000685	0.000685	CcSEcCtD
Gadodiamide—Oedema—Epirubicin—ovarian cancer	0.000675	0.000675	CcSEcCtD
Gadodiamide—Anaphylactic shock—Epirubicin—ovarian cancer	0.000675	0.000675	CcSEcCtD
Gadodiamide—Loss of consciousness—Doxorubicin—ovarian cancer	0.000673	0.000673	CcSEcCtD
Gadodiamide—Infection—Epirubicin—ovarian cancer	0.000671	0.000671	CcSEcCtD
Gadodiamide—Shock—Epirubicin—ovarian cancer	0.000664	0.000664	CcSEcCtD
Gadodiamide—Convulsion—Doxorubicin—ovarian cancer	0.000663	0.000663	CcSEcCtD
Gadodiamide—Nervous system disorder—Epirubicin—ovarian cancer	0.000662	0.000662	CcSEcCtD
Gadodiamide—Dizziness—Docetaxel—ovarian cancer	0.000662	0.000662	CcSEcCtD
Gadodiamide—Tachycardia—Epirubicin—ovarian cancer	0.000659	0.000659	CcSEcCtD
Gadodiamide—Hyperhidrosis—Epirubicin—ovarian cancer	0.000653	0.000653	CcSEcCtD
Gadodiamide—Myalgia—Doxorubicin—ovarian cancer	0.000652	0.000652	CcSEcCtD
Gadodiamide—Arthralgia—Doxorubicin—ovarian cancer	0.000652	0.000652	CcSEcCtD
Gadodiamide—Chest pain—Doxorubicin—ovarian cancer	0.000652	0.000652	CcSEcCtD
Gadodiamide—Anxiety—Doxorubicin—ovarian cancer	0.000649	0.000649	CcSEcCtD
Gadodiamide—Discomfort—Doxorubicin—ovarian cancer	0.000644	0.000644	CcSEcCtD
Gadodiamide—Dry mouth—Doxorubicin—ovarian cancer	0.000637	0.000637	CcSEcCtD
Gadodiamide—Vomiting—Docetaxel—ovarian cancer	0.000636	0.000636	CcSEcCtD
Gadodiamide—Rash—Docetaxel—ovarian cancer	0.000631	0.000631	CcSEcCtD
Gadodiamide—Hypotension—Epirubicin—ovarian cancer	0.000631	0.000631	CcSEcCtD
Gadodiamide—Dermatitis—Docetaxel—ovarian cancer	0.00063	0.00063	CcSEcCtD
Gadodiamide—Headache—Docetaxel—ovarian cancer	0.000627	0.000627	CcSEcCtD
Gadodiamide—Oedema—Doxorubicin—ovarian cancer	0.000625	0.000625	CcSEcCtD
Gadodiamide—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000625	0.000625	CcSEcCtD
Gadodiamide—Infection—Doxorubicin—ovarian cancer	0.000621	0.000621	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000615	0.000615	CcSEcCtD
Gadodiamide—Shock—Doxorubicin—ovarian cancer	0.000614	0.000614	CcSEcCtD
Gadodiamide—Nervous system disorder—Doxorubicin—ovarian cancer	0.000613	0.000613	CcSEcCtD
Gadodiamide—Tachycardia—Doxorubicin—ovarian cancer	0.00061	0.00061	CcSEcCtD
Gadodiamide—Paraesthesia—Epirubicin—ovarian cancer	0.000606	0.000606	CcSEcCtD
Gadodiamide—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000604	0.000604	CcSEcCtD
Gadodiamide—Dyspnoea—Epirubicin—ovarian cancer	0.000602	0.000602	CcSEcCtD
Gadodiamide—Somnolence—Epirubicin—ovarian cancer	0.0006	0.0006	CcSEcCtD
Gadodiamide—Nausea—Docetaxel—ovarian cancer	0.000594	0.000594	CcSEcCtD
Gadodiamide—Dyspepsia—Epirubicin—ovarian cancer	0.000594	0.000594	CcSEcCtD
Gadodiamide—Hypotension—Doxorubicin—ovarian cancer	0.000584	0.000584	CcSEcCtD
Gadodiamide—Fatigue—Epirubicin—ovarian cancer	0.000582	0.000582	CcSEcCtD
Gadodiamide—Pain—Epirubicin—ovarian cancer	0.000577	0.000577	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000569	0.000569	CcSEcCtD
Gadodiamide—Paraesthesia—Doxorubicin—ovarian cancer	0.000561	0.000561	CcSEcCtD
Gadodiamide—Dyspnoea—Doxorubicin—ovarian cancer	0.000557	0.000557	CcSEcCtD
Gadodiamide—Feeling abnormal—Epirubicin—ovarian cancer	0.000556	0.000556	CcSEcCtD
Gadodiamide—Somnolence—Doxorubicin—ovarian cancer	0.000555	0.000555	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000552	0.000552	CcSEcCtD
Gadodiamide—Dyspepsia—Doxorubicin—ovarian cancer	0.00055	0.00055	CcSEcCtD
Gadodiamide—Fatigue—Doxorubicin—ovarian cancer	0.000538	0.000538	CcSEcCtD
Gadodiamide—Urticaria—Epirubicin—ovarian cancer	0.000536	0.000536	CcSEcCtD
Gadodiamide—Pain—Doxorubicin—ovarian cancer	0.000534	0.000534	CcSEcCtD
Gadodiamide—Abdominal pain—Epirubicin—ovarian cancer	0.000534	0.000534	CcSEcCtD
Gadodiamide—Body temperature increased—Epirubicin—ovarian cancer	0.000534	0.000534	CcSEcCtD
Gadodiamide—Feeling abnormal—Doxorubicin—ovarian cancer	0.000515	0.000515	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000511	0.000511	CcSEcCtD
Gadodiamide—Hypersensitivity—Epirubicin—ovarian cancer	0.000497	0.000497	CcSEcCtD
Gadodiamide—Urticaria—Doxorubicin—ovarian cancer	0.000496	0.000496	CcSEcCtD
Gadodiamide—Body temperature increased—Doxorubicin—ovarian cancer	0.000494	0.000494	CcSEcCtD
Gadodiamide—Abdominal pain—Doxorubicin—ovarian cancer	0.000494	0.000494	CcSEcCtD
Gadodiamide—Asthenia—Epirubicin—ovarian cancer	0.000484	0.000484	CcSEcCtD
Gadodiamide—Pruritus—Epirubicin—ovarian cancer	0.000478	0.000478	CcSEcCtD
Gadodiamide—Diarrhoea—Epirubicin—ovarian cancer	0.000462	0.000462	CcSEcCtD
Gadodiamide—Hypersensitivity—Doxorubicin—ovarian cancer	0.00046	0.00046	CcSEcCtD
Gadodiamide—Asthenia—Doxorubicin—ovarian cancer	0.000448	0.000448	CcSEcCtD
Gadodiamide—Dizziness—Epirubicin—ovarian cancer	0.000446	0.000446	CcSEcCtD
Gadodiamide—Pruritus—Doxorubicin—ovarian cancer	0.000442	0.000442	CcSEcCtD
Gadodiamide—Vomiting—Epirubicin—ovarian cancer	0.000429	0.000429	CcSEcCtD
Gadodiamide—Diarrhoea—Doxorubicin—ovarian cancer	0.000427	0.000427	CcSEcCtD
Gadodiamide—Rash—Epirubicin—ovarian cancer	0.000426	0.000426	CcSEcCtD
Gadodiamide—Dermatitis—Epirubicin—ovarian cancer	0.000425	0.000425	CcSEcCtD
Gadodiamide—Headache—Epirubicin—ovarian cancer	0.000423	0.000423	CcSEcCtD
Gadodiamide—Dizziness—Doxorubicin—ovarian cancer	0.000413	0.000413	CcSEcCtD
Gadodiamide—Nausea—Epirubicin—ovarian cancer	0.000401	0.000401	CcSEcCtD
Gadodiamide—Vomiting—Doxorubicin—ovarian cancer	0.000397	0.000397	CcSEcCtD
Gadodiamide—Rash—Doxorubicin—ovarian cancer	0.000394	0.000394	CcSEcCtD
Gadodiamide—Dermatitis—Doxorubicin—ovarian cancer	0.000393	0.000393	CcSEcCtD
Gadodiamide—Headache—Doxorubicin—ovarian cancer	0.000391	0.000391	CcSEcCtD
Gadodiamide—Nausea—Doxorubicin—ovarian cancer	0.000371	0.000371	CcSEcCtD
